Back to search
Acquired Nasolacrimal Duct Obstruction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acquired Nasolacrimal Duct Obstruction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acquired Nasolacrimal Duct Obstruction trials you may qualify forPrimary acquired nasolacrimal duct obstruction
Primary acquired nasolacrimal duct obstruction (PANDO) is a lacrimal duct obstruction disease characterized by inflammatory fibrosis of the nasolacrimal duct, w…
The aim of DCR is to form a new, mucosa-lined pathway between the lacrimal sac and the nasal cavity where tears can bypass a lacrimal obstruction and drain dire…
All patients with epiphora or eye discharge that admitted to our ophthalmic plastic clinic in Farabi hospital will be systemically evaluated. Those with confirm…
While external DCR is the gold standard procedure for primary NLDO as well as complicated cases, SI with MMC could achieve comparable success rates in primary a…
Comparison between patients with nasolacrimal duct obstruction and healthy patients and the influence of their bacterial flora on the corneal epithelium.